CSB

Stanford School of Medicine

Chemical & Systems Biology

 
 

βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.

Posted by CSB Department on October 1, 2011

Ferreira JC, Brum PC, Mochly-Rosen D. (2011) J. Mol. Cell. Cardiol. 51(4):479-84 [PubMed]